Pathway Therapeutics Garners $200,000 New Financing

  • Feed Type
  • Date
    11/30/2012
  • Company Name
    Pathway Therapeutics
  • Mailing Address
    409 Illinois Street San Francisco, CA 94158
  • Company Description
    Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases.
  • Website
    http://www.pathwaytx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.